Steritas

Business Services · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

42 Pine St, Concord, Massachusetts, 0174...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1

About Steritas

Steritas, an IQVIA business, focuses on addressing glucocorticoid toxicity through innovative tools and public health initiatives. Their suite of products, including the Glucocorticoid Toxicity Index (GTI) and the STOX Suite, aims to measure and mitigate the adverse effects of long-term steroid use. They cater to a diverse clientele, including academic institutions, pharmaceutical companies, clinical research organizations, and healthcare professionals. By promoting steroid-sparing alternatives, Steritas seeks to improve patient outcomes and reduce healthcare costs associated with steroid toxicity.Explore more
Steritas's Social MediaPopular SearchesSteritas LLCSteritasSIC Code 87,873NAICS Code 54,541Show more

Steritas Org Chart

Martha Stone, Chief Executive Officer at Steritas
United States flag for contact location.

Chief Executive Officer

PhoneEmail

Is Steritas your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Steritas

Compare insights from companies similar to Steritas, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Steritas

<$5M
11-50
Private
-
2021
$16.3M
11-50
Private
$399.4M
2021
AJ
Andrew JordanChief Financial Officer
$7.8M
51-200
Private
-
-
N/A
$5.3M
11-50
Private
-
2021
OF
Olga FlaminiChief Medical Officer
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2021
AK
Alexis KafandoChief Scientist
<$5M
11-50
Private
$5.6M
-
TM
Touhidul MollaSenior Research Associate
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Steritas is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Steritas is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Steritas.

Steritas Tech Stack

Steritas News & Media

  • Steritas Announces Collaboration with argenx to Advance Evidence for Novel Steroid-sparing Therapeutics

    BOSTON--(BUSINESS WIRE)--Steritas LLC., a company dedicated to enhancing care for steroid-treated patients, today announced a licensing agreement with argenx, a global immunology company, for use of its STOX® Suite of steroid-toxicity clinical outcome assessments (COAs) across argenx’s development programs for differentiated immunology therapeutics. The STOX Suite comprises first-in-class digital instruments that provide a standardized and validated measure of the full scope of steroid-toxicity
Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Steritas

What is Steritas's official website?
Steritas's official website is www.steritas.com
What is Steritas's Revenue?
Steritas's revenue is <$5 Million
What is Steritas's SIC code?
Steritas's SIC: 87,873
What is Steritas's NAICS code?
Steritas's NAICS: 54,541
How many employees does Steritas have?
Steritas has 11-50 employees
What industry does Steritas belong to?
Steritas is in the industry of: Business Services, Research & Development
What is Steritas competition?
Steritas top competitors include: Myrtelle, IonisTrials, GenrAb, Aceragen
What technology does Steritas use?
Some of the popular technologies that Steritas uses are: WordPress.org, reCAPTCHA, Cloudflare Website Optimization, Cloudflare CDN
What does Steritas do?

Steritas, an IQVIA business, focuses on addressing glucocorticoid toxicity through innovative tools and public health initiatives. Their suite of products, including the Glucocorticoid Toxicity Index (GTI) and the STOX Suite, aims to measure and mitigate the adverse effects of long-term steroid use. They cater to a diverse clientele, including acad... emic institutions, pharmaceutical companies, clinical research organizations, and healthcare professionals. By promoting steroid-sparing alternatives, Steritas seeks to improve patient outcomes and reduce healthcare costs associated with steroid toxicity.Read More

What are Steritas social media links?
Steritas Linkedin page
Is Steritas a public company?
Steritas is private company therefore does not currently have an official ticker symbol
See more information about Steritas

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.